Download PDF
Erfahrungsheilkunde 2017; 66(03): 154-158
DOI: 10.1055/s-0043-112332
Praxis
© Karl F. Haug Verlag in MVS Medizinverlage Stuttgart GmbH & Co. KG

Phytotherapeutische Optionen beim Reizdarmsyndrom

Sigrun Chrubasik-Hausmann
Further Information

Publication History

Publication Date:
21 July 2017 (online)

    Permissions and Reprints

Zusammenfassung

Etwa 15 % der Bevölkerung in Deutschland leiden an einem Reizdarmsyndrom nach den Kriterien ROM III. Klinisch geht das Reizdarmsyndrom mit einem Blähbauch, Bauchschmerzen und Durchfall oder Verstopfung einher. Das Reizdarmsyndrom kann viele Ursachen haben, die bei der Behandlung berücksichtigt werden müssen. Zu den pflanzlichen Behandlungen des Reizdarmsyndroms gehören Hagebuttenpulver, eine als Fertigpräparat verfügbare Pflanzenextrakt-Kombination, Kapseln mit Pfefferminzöl und die pflanzlichen Antidepressiva Johanniskraut oder Lavendelöl. Bei Oberbauchbeschwerden mit Sodbrennen empfiehlt sich auch ein Saft aus rohen Kartoffeln. Im Einzelfall können zudem Kräutertees und Urtinkturen hilfreich sein.

Abstract

About 15 % of the German population suffer from irritable bowel syndrome (IBS) according to the ROM III criteria. IBS is characterized by meteorism, abdominal pain and diarrhea or constipation. IBS may have various origins which have to be considered in the treatment schedule. Herbal treatment options include rose hip peel or pseudofruit powders, a proprietary mixture of different herbal extracts, capsules containing peppermint oil and herbal antidepressants such as St. John’s wort or lavender oil. In patients with upper abdominal complaints and heartburh, freshly squeezed potatoe juice is indicated. In individual cases herbal teas or mother tinctures may be of help.

Schlüsselwörter

Reizdarmsyndrom - Blähbauch - Bauchschmerzen - Durchfall - Verstopfung - Behandlung

Key words

Irritable bowel syndrome - bloating - abdominal pain - diarrhea - constipation - treatment
 

  • Literatur

  • 1 Alam MS, Roy PK, Miah AR. et al. Efficacy of peppermint oil in diarrhea predominant IBS – a double blind randomized placebo – controlled study. Mymensingh Med J 2013; 22: 27-30
    PubMedGoogle Scholar
  • 2 Allescher HD, Wagner H. STW 5/Iberogast: multi-target-action for treatment of functional dyspepsia and irritable bowel syndrome. Wien Med Wochenschr 2007; 157: 301-7
    CrossrefPubMedGoogle Scholar
  • 3 Cash BD, Epstein MS, Shah SM. A novel delivery system of peppermint oil is an effective therapy for irritable bowel syndrome symptoms. Dig Dis Sci 2016; 61: 560-571
    CrossrefPubMedGoogle Scholar
  • 4 Chrubasik S, Chrubasik C, Torda T. et al. Efficacy and tolerability of potato juice in dyspeptic patients: a pilot study. Phytomedicine 2006; a 13: 11-15
    CrossrefPubMedGoogle Scholar
  • 5 Chrubasik S, Boyko T, Filippov Y. et al. Further evidence on the effectiveness of potato juice in dyspeptic complaints. Phytomedicine 2006; b 13: 596-597
    CrossrefPubMedGoogle Scholar
  • 6 Halmos EP. When the low FODMAP diet does not work. J Gastroenterol Hepatol 2017; (Suppl. 32) 1: 69-72
    PubMedGoogle Scholar
  • 7 Holtmann G, Adam B, Vinson B. Evidence-based medicine and phytotherapy for functional dyspepsia and irritable bowel syndrome: a systematic analysis of evidence for the herbal preparation Iberogast. Wien Med Wochenschr 2004; 154: 528-534
    CrossrefPubMedGoogle Scholar
  • 8 Khanna R, MacDonald JK, Levesque BG. Peppermint oil for the treatment of irritable bowel syndrome: a systematic review and meta-analysis. J Clin Gastroenterol 2014; 48: 505-512
    PubMedGoogle Scholar
  • 9 Melzer J, Rösch W, Reichling J. et al. Meta-analysis: phytotherapy of functional dyspepsia with the herbal drug preparation STW 5 (Iberogast). Aliment Pharmacol Ther 2004; 20: 1279-1287
    CrossrefPubMedGoogle Scholar
  • 10 Merat S, Khalili S, Mostajabi P. et al. The effect of entericcoated, delayed-release peppermint oil on irritable bowel syndrome. Dig Dis Sci 2010; 55: 1385-1390
    CrossrefPubMedGoogle Scholar
  • 11 Ruepert L, Quartero AO, de Wit NJ. et al. Bulking agents, antispasmodics and antidepressants for the treatment of irritable bowel syndrome. Cochrane Database Syst Rev.. 2011 Aug 10; (8): CD003460
    PubMedGoogle Scholar
  • 12 Sáez-González E, Conde I, Díaz-Jaime FC. et al. Iberogast-induced severe hepatotoxicity leading to liver transplantation. Am J Gastroenterol 2016; 111: 1364-1365
    PubMedGoogle Scholar
  • 13 Teschke R, Frenzel C, Glass X. et al. Greater Celandine hepatotoxicity: a clinical review. Ann Hepatol 2012; 11: 838-848
    PubMedGoogle Scholar
  • 14 Von Arnim U, Peitz U, Vinson B. et al. STW 5, a phytopharmacon for patients with functional dyspepsia: results of a multicenter, placebo-controlled double-blind study. Am J Gastroenterol 2007; 102: 1268-1275
    CrossrefPubMedGoogle Scholar
  • 15 Wittkamp P, Andresen V, Broicher W. Prävalenz des Reizdarmsyndroms nach den Rom-III-Kriterien in Deutschland und Zusammenhänge mit potentiellen Risikofaktoren. Z Gastroenterol 2012; 50-V36
    PubMedGoogle Scholar